Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Personality Traits and Physical Complaints in Patients With Acromegaly: A Cross Sectional Multi-Center Study With Analysis of Influencing Factors.

Zimmermann A, Zwerenz R, Droste M, Schöfl C, Strasburger CJ, Plöckinger U, Ziagaki A, Honegger J, Dixius A, Millaku B, Toenges G, Beutel ME, Weber MM.

Front Endocrinol (Lausanne). 2018 Jul 17;9:391. doi: 10.3389/fendo.2018.00391. eCollection 2018.

2.

Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYN.

Valassi E, Feelders R, Maiter D, Chanson P, Yaneva M, Reincke M, Krsek M, Tóth M, Webb SM, Santos A, Paiva I, Komerdus I, Droste M, Tabarin A, Strasburger CJ, Franz H, Trainer PJ, Newell-Price J, Wass JA, Papakokkinou E, Ragnarsson O; ERCUSYN Study Group.

Clin Endocrinol (Oxf). 2018 Jun;88(6):787-798. doi: 10.1111/cen.13600. Epub 2018 Apr 16.

PMID:
29574994
3.

Antitumor Activity of DLX1008, an Anti-VEGFA Antibody Fragment with Low Picomolar Affinity, in Human Glioma Models.

Szabó E, Phillips DJ, Droste M, Marti A, Kretzschmar T, Shamshiev A, Weller M.

J Pharmacol Exp Ther. 2018 May;365(2):422-429. doi: 10.1124/jpet.117.246249. Epub 2018 Mar 5.

PMID:
29507055
4.

Preoperative medical treatment in Cushing's syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN.

Valassi E, Franz H, Brue T, Feelders RA, Netea-Maier R, Tsagarakis S, Webb SM, Yaneva M, Reincke M, Droste M, Komerdus I, Maiter D, Kastelan D, Chanson P, Pfeifer M, Strasburger CJ, Tóth M, Chabre O, Krsek M, Fajardo C, Bolanowski M, Santos A, Trainer PJ, Wass JAH, Tabarin A; ERCUSYN Study Group.

Eur J Endocrinol. 2018 Apr;178(4):399-409. doi: 10.1530/EJE-17-0997. Epub 2018 Feb 12.

PMID:
29440375
5.

Design of novel materials for additive manufacturing - Isotropic microstructure and high defect tolerance.

Günther J, Brenne F, Droste M, Wendler M, Volkova O, Biermann H, Niendorf T.

Sci Rep. 2018 Jan 22;8(1):1298. doi: 10.1038/s41598-018-19376-0.

6.

[Diagnostics and treatment of acromegaly : Necessity for targeted monitoring of comorbidities].

Petersenn S, Christ-Crain M, Droste M, Finke R, Flitsch J, Kreitschmann-Andermahr I, Luger A, Schopohl J, Stalla G.

Internist (Berl). 2017 Nov;58(11):1171-1182. doi: 10.1007/s00108-017-0331-z. German.

PMID:
29027568
7.

Incidence of myocardial infarction and stroke in acromegaly patients: results from the German Acromegaly Registry.

Schöfl C, Petroff D, Tönjes A, Grussendorf M, Droste M, Stalla G, Jaursch-Hancke C, Störmann S, Schopohl J.

Pituitary. 2017 Dec;20(6):635-642. doi: 10.1007/s11102-017-0827-5.

PMID:
28808855
8.

Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN.

Valassi E, Franz H, Brue T, Feelders RA, Netea-Maier R, Tsagarakis S, Webb SM, Yaneva M, Reincke M, Droste M, Komerdus I, Maiter D, Kastelan D, Chanson P, Pfeifer M, Strasburger CJ, Tóth M, Chabre O, Tabarin A, Krsek M, Fajardo C, Bolanowski M, Santos A, Wass JA, Trainer PJ; ERCUSYN Study Group.

Eur J Endocrinol. 2017 May;176(5):613-624. doi: 10.1530/EJE-16-0967.

9.

Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly.

Strasburger CJ, Karavitaki N, Störmann S, Trainer PJ, Kreitschmann-Andermahr I, Droste M, Korbonits M, Feldmann B, Zopf K, Sanderson VF, Schwicker D, Gelbaum D, Haviv A, Bidlingmaier M, Biermasz NR.

Eur J Endocrinol. 2016 Mar;174(3):355-62. doi: 10.1530/EJE-15-1042. Epub 2015 Dec 18.

10.

Diagnosis of Primary Hypophysitis in Germany.

Honegger J, Schlaffer S, Menzel C, Droste M, Werner S, Elbelt U, Strasburger C, Störmann S, Küppers A, Streetz-van der Werf C, Deutschbein T, Stieg M, Rotermund R, Milian M, Petersenn S; Pituitary Working Group of the German Society of Endocrinology.

J Clin Endocrinol Metab. 2015 Oct;100(10):3841-9. doi: 10.1210/jc.2015-2152. Epub 2015 Aug 11.

PMID:
26262437
11.

The Incidence of Cancer Among Acromegaly Patients: Results From the German Acromegaly Registry.

Petroff D, Tönjes A, Grussendorf M, Droste M, Dimopoulou C, Stalla G, Jaursch-Hancke C, Mai M, Schopohl J, Schöfl C.

J Clin Endocrinol Metab. 2015 Oct;100(10):3894-902. doi: 10.1210/jc.2015-2372. Epub 2015 Aug 5.

PMID:
26244491
12.

Prediction of therapy response in acromegalic patients under pegvisomant therapy within the German ACROSTUDY cohort.

Sievers C, Baur DM, Schwanke A, Buchfelder M, Droste M, Mann K, Stalla GK.

Pituitary. 2015 Dec;18(6):916-23. doi: 10.1007/s11102-015-0673-2.

PMID:
26224528
13.

Treatment of Primary Hypophysitis in Germany.

Honegger J, Buchfelder M, Schlaffer S, Droste M, Werner S, Strasburger C, Störmann S, Schopohl J, Kacheva S, Deutschbein T, Stalla G, Flitsch J, Milian M, Petersenn S, Elbelt U; Pituitary Working Group of the German Society of Endocrinology.

J Clin Endocrinol Metab. 2015 Sep;100(9):3460-9. doi: 10.1210/jc.2015-2146. Epub 2015 Jun 19.

PMID:
26091204
14.

Frequency of AIP gene mutations in young patients with acromegaly: a registry-based study.

Schöfl C, Honegger J, Droste M, Grussendorf M, Finke R, Plöckinger U, Berg C, Willenberg HS, Lammert A, Klingmüller D, Jaursch-Hancke C, Tönjes A, Schneidewind S, Flitsch J, Bullmann C, Dimopoulou C, Stalla G, Mayr B, Hoeppner W, Schopohl J.

J Clin Endocrinol Metab. 2014 Dec;99(12):E2789-93. doi: 10.1210/jc.2014-2094.

PMID:
25093619
15.

Therapy of acromegalic patients exacerbated by concomitant type 2 diabetes requires higher pegvisomant doses to normalise IGF1 levels.

Droste M, Domberg J, Buchfelder M, Mann K, Schwanke A, Stalla G, Strasburger CJ.

Eur J Endocrinol. 2014 Jul;171(1):59-68. doi: 10.1530/EJE-13-0438. Erratum in: Eur J Endocrinol. 2014 Dec;171(6):X5.

16.

GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases.

Zoicas F, Droste M, Mayr B, Buchfelder M, Schöfl C.

Eur J Endocrinol. 2013 Apr 15;168(5):699-706. doi: 10.1530/EJE-12-0997. Print 2013 May.

17.

Efficacy and acceptability of lanreotide Autogel® 120 mg at different dose intervals in patients with acromegaly previously treated with octreotide LAR.

Schopohl J, Strasburger CJ, Caird D, Badenhoop K, Beuschlein F, Droste M, Plöckinger U, Petersenn S; German Lanreotide Study Group.

Exp Clin Endocrinol Diabetes. 2011 Mar;119(3):156-62. doi: 10.1055/s-0030-1267244. Epub 2010 Nov 17.

PMID:
21086246
18.

Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control.

Berg C, Petersenn S, Lahner H, Herrmann BL, Buchfelder M, Droste M, Stalla GK, Strasburger CJ, Roggenbuck U, Lehmann N, Moebus S, Jöckel KH, Möhlenkamp S, Erbel R, Saller B, Mann K; Investigative Group of the Heinz Nixdorf Recall Study and the German Pegvisomant Observational Study Board and Investigators.

J Clin Endocrinol Metab. 2010 Aug;95(8):3648-56. doi: 10.1210/jc.2009-2570. Epub 2010 May 12.

PMID:
20463098
19.

Change of symptoms and perceived health in acromegalic patients on pegvisomant therapy: a retrospective cohort study within the German Pegvisomant Observational Study (GPOS).

Sievers C, Brübach K, Saller B, Schneider HJ, Buchfelder M, Droste M, Mann K, Strasburger CJ, Stalla GK; German Pegvisomant Investigators.

Clin Endocrinol (Oxf). 2010 Jul;73(1):89-94. doi: 10.1111/j.1365-2265.2009.03773.x. Epub 2009 Dec 29.

PMID:
20050861
20.

The German ACROSTUDY: past and present.

Buchfelder M, Schlaffer S, Droste M, Mann K, Saller B, Brübach K, Stalla GK, Strasburger CJ; German Pegvisomant Observational Study.

Eur J Endocrinol. 2009 Nov;161 Suppl 1:S3-S10. doi: 10.1530/EJE-09-0350. Epub 2009 Aug 14.

21.

Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study.

Buchfelder M, Weigel D, Droste M, Mann K, Saller B, Brübach K, Stalla GK, Bidlingmaier M, Strasburger CJ; Investigators of German Pegvisomant Observational Study.

Eur J Endocrinol. 2009 Jul;161(1):27-35. doi: 10.1530/EJE-08-0910. Epub 2009 May 1.

22.

Experience from the German pegvisomant observational study.

Strasburger CJ, Buchfelder M, Droste M, Mann K, Stalla GK, Saller B; German Pegvisomant Investigators.

Horm Res. 2007;68 Suppl 5:70-3. doi: 10.1159/000110481. Epub 2007 Dec 10.

PMID:
18174713
23.

Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study.

Schreiber I, Buchfelder M, Droste M, Forssmann K, Mann K, Saller B, Strasburger CJ; German Pegvisomant Investigators.

Eur J Endocrinol. 2007 Jan;156(1):75-82.

24.

Elevated transaminases during medical treatment of acromegaly: a review of the German pegvisomant surveillance experience and a report of a patient with histologically proven chronic mild active hepatitis.

Biering H, Saller B, Bauditz J, Pirlich M, Rudolph B, Johne A, Buchfelder M, Mann K, Droste M, Schreiber I, Lochs H, Strasburger CJ; German pegvisomant investigators.

Eur J Endocrinol. 2006 Feb;154(2):213-20.

25.

Noninvasive measurement of cell volume changes by negative staining.

Droste MS, Biel SS, Terstegen L, Wittern KP, Wenck H, Wepf R.

J Biomed Opt. 2005 Nov-Dec;10(6):064017.

PMID:
16409082
26.
27.
28.

Cytochrome-c oxidase from Saccharomyces cerevisiae.

Poyton RO, Goehring B, Droste M, Sevarino KA, Allen LA, Zhao XJ.

Methods Enzymol. 1995;260:97-116. No abstract available.

PMID:
8592475
29.

Molecular cloning and expression of a novel type V adenylyl cyclase from rabbit myocardium.

Wallach J, Droste M, Kluxen FW, Pfeuffer T, Frank R.

FEBS Lett. 1994 Feb 7;338(3):257-63.

30.

Selective non-operative management of pseudoaneurysms and arteriovenous fistulae complicating femoral artery catheterization.

Allen BT, Munn JS, Stevens SL, Sicard GA, Anderson CB, Droste ML, Ludbrook PA.

J Cardiovasc Surg (Torino). 1992 Jul-Aug;33(4):440-7.

PMID:
1527148
31.

Mitochondrial DNA deletions and cytochrome c oxidase deficiency in muscle fibres.

Oldfors A, Larsson NG, Holme E, Tulinius M, Kadenbach B, Droste M.

J Neurol Sci. 1992 Jul;110(1-2):169-77.

PMID:
1324295
32.

Immunohistochemical demonstration of fibre type-specific isozymes of cytochrome c oxidase in human skeletal muscle.

Romero N, Marsac C, Fardeau M, Droste M, Schneyder B, Kadenbach B.

Histochemistry. 1990;94(2):211-5.

PMID:
2162812
33.
34.

Nucleotide sequence of cDNA encoding subunit IV of cytochrome c oxidase from fetal rat liver.

Gopalan G, Droste M, Kadenbach B.

Nucleic Acids Res. 1989 Jun 12;17(11):4376. No abstract available.

35.

Nucleotide sequence of cDNA encoding subunit Va from rat heart cytochrome c oxidase.

Droste M, Schon E, Kadenbach B.

Nucleic Acids Res. 1989 Jun 12;17(11):4375. No abstract available.

36.

Cytochrome c oxidase deficiency in subacute necrotizing encephalopathy (Leigh syndrome).

Hayasaka K, Brown GK, Danks DM, Droste M, Kadenbach B.

J Inherit Metab Dis. 1989;12(3):247-56.

PMID:
2559245
37.

Cytochrome oxidase deficiency: immunological studies of skeletal muscle mitochondrial fractions.

Shepherd IM, Birch-Machin MA, Johnson MA, Sherratt HS, Aynsley-Green A, Droste M, Kadenbach B, Stephenson JB, King MD, Dick DJ, et al.

J Neurol Sci. 1988 Nov;87(2-3):265-74.

PMID:
2850350
38.

Immunocytochemical studies of cytochrome oxidase subunits in skeletal muscle of patients with partial cytochrome oxidase deficiencies.

Johnson MA, Kadenbach B, Droste M, Old SL, Turnbull DM.

J Neurol Sci. 1988 Oct;87(1):75-90.

PMID:
2848095
39.
40.

Complexity of nucleus-encoded genes of mammalian cytochrome c oxidase.

Cao XN, Hengst L, Schlerf A, Droste M, Mengel T, Kadenbach B.

Ann N Y Acad Sci. 1988;550:337-47. No abstract available.

PMID:
2854406
41.

Immunochemical study in three patients with cytochrome c oxidase deficiency presenting Leigh's encephalomyelopathy.

Miyabayashi S, Ito T, Abukawa D, Narisawa K, Tada K, Tanaka M, Ozawa T, Droste M, Kadenbach B.

J Inherit Metab Dis. 1987;10(3):289-92. No abstract available.

PMID:
2828763
42.
43.

[Thrombocytopenia in Basedow disease].

Droste M, Rössler R.

Med Welt. 1983 Mar 11;34(10):297-301. German. No abstract available.

PMID:
6687748
44.

The consumer and the health care professional-contented marriage or shotgun wedding?

Droste MA.

NLN Publ. 1978;(52-1727):29-34. No abstract available.

PMID:
248675
45.

Guidelines for establishing a cooperative relationship between a hospital and an educational institution offering a pre-service program in nursing.

Scott JK, Laverdier R, Droste MA, Drake ME.

Hosp Prog. 1970 Apr;51(4):56-60. No abstract available.

PMID:
5436433

Supplemental Content

Loading ...
Support Center